CD38 Targeting Holds Potential for the Treatment of Aggressive Refractory Cutaneous T-Cell Lymphomas

Affiliations

• ¹ Department of Dermatology and Venereology, University Hospital Centre (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
• ² Department of Immunology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
• ³ Department of Dermatology and Venereology, University Hospital Centre (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland; Department of Immunology, University Hospital Zurich, University of Zurich, Zurich, Switzerland; Department of Dermatology, Hospital 12 de Octubre, Medical School, University Complutense, Madrid, Spain. Electronic address: emmanuella.guenova@unil.ch.